Work

Efficacy of Actinium-225–Labeled Fully Human Anti–MUC-16 Radioimmunoconjugate against MUC-16–Positive Ovarian and Pancreatic Ductal Adenocarcinoma Xenograft Models

Year: 2026

Type: article

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-26-0326

Authors: Hanan Babeker, Emmanuel Nwangele, Alissar Monzer, Jessica Pougoue Ketchemen, Katrina E. Bato, Fabrice N. Njotu, Anjong F. Tikum, Therese Mercado, Alireza Doroudi, Emina Torlakovic, John R. Gordon, Maruti Uppalapati, Humphrey Fonge

Institutions: University of Saskatchewan, Université Laval, Centre de recherche du CHU de Québec-Université Laval, Royal University Hospital

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Fonds de recherche du Québec – Nature et technologies, Institute of Cancer Research

Awards: G434096094, G9000368873

OpenAlex ID: W7203683119

FWCI:

Cites:

Cited by:

Related to: